medical use of titanium dioxide

Testing samples were made mixing 100 uL of TiO2NPs suspensions (0.2 mg/mL and 0.02 mg/mL) and vitamins@P25TiO2NPs (0.2 mg/mL and 0.02 mg/mL) with 100 μL ATCC 29,213 methicillin-sensitive Staphylococcus aureus (MSSA) (107 in PBS, pH 7). Controls were made replacing nanoparticles with the same volume of PBS. The concentrations of nanoparticle suspensions were chosen based on the FDA approved maximal and the minimal amount usually found in sunscreens, which are 20% and 2% (this is equivalent to 0.2 mg/mL and 0.02 mg/mL for nanoparticles suspensions). The cream concentration, on the other hand, was an intermediate value of 10%.

...

The first commercial production of TiO2 began in the early 20th century, using the sulfate process. This method involved reacting ilmenite ore with sulfuric acid to produce titanium sulfate, which was then calcined to obtain titanium dioxide. However, this process had several drawbacks, including high energy consumption, generation of large amounts of waste, and release of harmful gases such as sulfur dioxide. As a result, many factories transitioned to the chloride process, which offers higher purity TiO2 and reduced environmental impact.

...